Delivery Order SPE2DB22D1106-SPE2DB25FFCZ0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin PH 1% Solution in 60ML quantities, with a contract ceiling value of $1,179.36. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,401.76 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% Dextrose solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the company's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clindamycin PH 1% Solution 60ml with a ceiling value of $1,581.85 under a firm fixed price arrangement. The award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and utilized no set-aside designation, indicating the award was made through open competition. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.64 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Clindamycin 900 mg/50 ml in Dextrose 5% Water solution. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the competitive nature of the procurement. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.16 for the supply of Clindamycin 900 mg/50 mL in dextrose 5% water solution on August 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin Phosphate 1% Lotion in 60ml quantities, with a ceiling value of $3,766.03. This competitive award, issued with firm fixed pricing and no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Clindamycin HCl 300 mg capsules (100-count units) with a ceiling value of $1,200.84. This firm fixed-price delivery order, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen's larger...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCZ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Clindamycin PH 1% Solution in 60ml quantities, with a ceiling value of $3,394.38 and a firm fixed price structure. This delivery order is classified as non-set-aside and represents a competitively awarded contract with an ultimate completion date of August 13, 2025. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract serves as the vehicle through which AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for the antibiotic clindamycin represents a routine pharmaceutical fulfillment under this strategic framework designed to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/12/25 |